FindTrial
Sign In

A comparative study between two drugs, Midazolam and Ketamine, given intravenously, along with Propofol in General Anaesthesia,

A prospective comparative study between Midazolam and Ketamine given intravenously as coinducing agents for Propofol in General Anaesthesia.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030735
Enrollment
60
Registered
2021-01-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I978- Other intraoperative and postprocedural complications and disorders of the circulatory system, not elsewhere classified

Interventions

Intervention1: Ketamine: Dose-0.3mg/kg Route-intravenous Frequency-once Intervention2: Midazolam: Dose-0.03mg/kg Route-intravenous Frequency-once

Sponsors

Dr Sachin M
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA CLASS 1 & 2 patients scheduled to undergo elective General Surgery or Orthopedics surgery under General Anaesthesia with Propofol as iv induction agents

Exclusion criteria

Exclusion criteria: Patients with h/o known allergy to study drugs Patients with significant cardiovascular or respiratory disorders

Design outcomes

Secondary

MeasureTime frame
NilTimepoint: Nil—

Primary

MeasureTime frame
To compare dose reduction of Propofol. To compare associated hemodynamic changes.Timepoint: At baseline—

Countries

India

Contacts

Public ContactDr Sachin M

Kempegowda Institute of Medical Sciences, Bengaluru

dr.ashwinivijay.a@gmail.com9341231411

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026